Two female friends enjoy a cup of coffee and conversation

7 Easy-to-Influence Survey Responses for Better Medicare Advantage Star Ratings

It’s too late to do anything about 2023 Medicare Star ratings. But it’s never too soon to influence what the next 1,000 random members surveyed will say about your plan.

Read More
  • Select Category
  • Chronic Conditions
  • Engagement
  • Events
  • Healthcare Costs
  • Media
  • Medication Adherence
  • Member Stories
  • Our Team
  • Privacy and Security
  • Product
  • Success Stories
  • Transparency
  • Uncategorized
Select Category
  • Select Category
  • Chronic Conditions
  • Engagement
  • Events
  • Healthcare Costs
  • Media
  • Medication Adherence
  • Member Stories
  • Our Team
  • Privacy and Security
  • Product
  • Success Stories
  • Transparency
  • Uncategorized
Executive meeting with medical specialists and pharmacy professionals

The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus

Up to 10 competing products for Humira are on the way in 2023. What should health plans and plan sponsors be following as the biosimilars landscape takes shape?

Read More
Close-up of blood sugar meter and healthy food for controlling diabetes

Diabetes by the Numbers, and the Importance of Affordable Medication

Some lesser-known facts about this chronic condition underscore the importance of medication adherence, and the positive impact RxSS can have on members with diabetes.

Read More
An image of President Biden signing the Inflation Reduction Act

A Q&A on the IRA

The Inflation Reduction Act has the potential to lower prescription drug costs for millions of Americans and raise them for millions more. Who stands to gain or lose?

Read More
Pharmacist in a pharmacy taking inventory of medications in stock

The Adderall Shortage Is Real – RxSS Can Help

We know many members are scrambling to find pharmacies with the common ADHD medication in stock. With this and other drug shortages, RxSS can be an invaluable resource.

Read More
A syringe containing an expensive biologic drug like Humira

Humira and the Looming Biosimilar Boom

A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?

Read More
Two doctors and two pharmacists consulting one another in a clinical setting

No, We’re Not Your Doctor—Just Transparency You Can Trust

Members shouldn’t confuse our clinical suggestions for intervention. Medication decisions are between patient and doctor. RxSS informs those discussions, and makes it easy to make a change.

Read More
A woman using a laptop to access her health plan's pharmacy savings tool.

Considering a PBM’s Savings Tool? 10 Questions to Ask Right Now

Free PBM tools can help members get more from their pharmacy benefits, maybe even save on certain prescriptions. What more can you ask for? Quite a bit, actually.

Read More
A man and woman researching medical and prescription costs online

A Glimpse of the Holy Grail for Healthcare Cost Transparency

Seemingly since the beginning of time, consumers have rarely known what a doctor visit, medical procedure or medication will cost until it’s time to pay. Fortunately, things are starting to change.

Read More

Specialty Copay Programs – Accumulate, Maximize or Avoid?

Utilization of specialty medications continues to rise, and so do costs for patients and plan sponsors. Thanks to these rising costs, we see more plans choosing to implement copay adjustment programs, but it’s crucial to understand how they fit into your benefit and where they improve or hinder your plan.

Read More

Stay COnnected

Share your email and once a month we’llsend you industry news and insights.

newsletter signup graphic
X